Page last updated: 2024-10-21

pk 11195 and Dyskinesia, Drug-Induced

pk 11195 has been researched along with Dyskinesia, Drug-Induced in 2 studies

PK-11195 : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 1-(2-chlorophenyl)isoquinoline-3-carboxylic acid with the amino group of sec-butylmethylamine

Dyskinesia, Drug-Induced: Abnormal movements, including HYPERKINESIS; HYPOKINESIA; TREMOR; and DYSTONIA, associated with the use of certain medications or drugs. Muscles of the face, trunk, neck, and extremities are most commonly affected. Tardive dyskinesia refers to abnormal hyperkinetic movements of the muscles of the face, tongue, and neck associated with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS). (Adams et al., Principles of Neurology, 6th ed, p1199)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Raghavendra, V1
Naidu, PS1
Kulkarni, SK1
Weizman, R1
Tanne, Z1
Karp, L1
Tyano, S1
Gavish, M1

Other Studies

2 other studies available for pk 11195 and Dyskinesia, Drug-Induced

ArticleYear
Reversal of reserpine-induced vacuous chewing movements in rats by melatonin: involvement of peripheral benzodiazepine receptors.
    Brain research, 2001, Jun-15, Volume: 904, Issue:1

    Topics: Adrenergic alpha-Antagonists; Adrenergic Uptake Inhibitors; Animals; Antineoplastic Agents; Dose-Res

2001
Peripheral-type benzodiazepine-binding sites in platelets of schizophrenics with and without tardive dyskinesia.
    Life sciences, 1986, Aug-11, Volume: 39, Issue:6

    Topics: Adult; Binding Sites; Blood Platelets; Dyskinesia, Drug-Induced; Female; Humans; Isoquinolines; Male

1986